BIO logo

Biofarm S.A. Stock Price

BVB:BIO Community·RON 1.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

BIO Share Price Performance

RON 1.25
0.60 (91.54%)
RON 1.25
0.60 (91.54%)
Price RON 1.25

BIO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet and pays a dividend.

0 Risks
3 Rewards

Biofarm S.A. Key Details

RON 319.3m

Revenue

RON 48.9m

Cost of Revenue

RON 270.4m

Gross Profit

RON 169.8m

Other Expenses

RON 100.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 15, 2026
0.10
84.68%
31.51%
0.2%
View Full Analysis

About BIO

Founded
1921
Employees
369
CEO
Catalin Vicol
WebsiteView website
www.biofarm.ro

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, medical devices, and other products. The company also exports its products in Albania, Azerbaijan, Georgia, Jordan, Iraq, Kyrgyzstan, Malta, Republic of Moldova, Serbia, and Hungary. Biofarm S.A. was incorporated in 1921 and is based in Bucharest, Romania.

Recent BIO News & Updates

Biofarm (BVB:BIO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 01
Biofarm (BVB:BIO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Recent updates

No updates